New shot aims to help HIV patients fight Cancer-Causing virus
NCT ID NCT07090174
First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 28 times
Summary
This study tests a new drug called PDS0101 in 27 adults with both HIV and HPV type 16. The goal is to see if it is safe and can boost the body's immune response against HPV, which can cause cancers like anal and cervical cancer. All participants will receive three doses of the drug and be monitored for side effects and immune changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center/Albert Einstein College of Medicine
The Bronx, New York, 10461, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Puerto Rico
San Juan, 00935, Puerto Rico
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Weill Cornell Medical College
New York, New York, 10010, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.